Medical device major Medtronic, Inc. (MDT) has won the CE (Conformité Européenne) Mark for its TYRX Absorbable Antibacterial Envelope that is designed to contain a pacemaker pulse generator or a ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
TYRX, Inc.Robert White, 732-246-8676President and Chief Executive OfficerorFor Media:Kureczka/Martin AssociatesJoan Kureczka, 415-690-0210 Use of TYRX, Inc.’s AIGISRx Antibacterial Envelope ...
DUBLIN, Sept. 16, 2020 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced new data from the landmark WRAP-IT study, showing the TYRX™ Absorbable ...
Tyrx won Canadian regulatory approval for its next-generation antibacterial envelope. The new iteration is also designed to reduce the risk of infections after pacemaker or ICD implant surgeries, but ...
MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--TYRX, Inc., the leader in the commercialization of implantable medical devices designed to help reduce surgical-site infections associated with implantable ...
Long-term Citadel/Centurion Clinical Trial Findings and Independent Data Presented at Heart Rhythm Society 36 th Annual Scientific Sessions The Citadel/Centurion Clinical Trials are the first ...
TYRX, Inc. announced today that it has been named to the “Fierce 15” list, designating it as one of the leading medical device and diagnostic companies of 2012. Editors Mark Hollmer and Damian Garde, ...
Monmouth Junction, NJ (October 19, 2010) – Patients undergoing CIED (Cardiac Implantable Electronic Device) implantation with TYRX, Inc.'s FDA-cleared AIGISRx Antibacterial Envelope enjoyed a 99.5% ...
Medtronic plc (NYSE:MDT) today announced results from the landmark Worldwide Randomized Antibiotic Envelope Infection Prevention Trial (WRAP-IT), which demonstrated the TYRX(TM) Absorbable ...
Proceeds Will Support Commercialization of the AIGISrx(TM) CRMD Anti-Bacterial Envelope and Development and Launch of Additional Drug-Eluting Devices in the TyRx Pipeline MONMOUTH JUNCTION, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results